In a similar way, BTK has been shown to be constitutively activated by BCR-ABL in Ph+ ALL cells thereby bypassing the pre-B cell receptor and providing a continuous survival signal [47]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.